NPPC Human

Natriuretic Peptide C Human Recombinant
Shipped with Ice Packs
In Stock

Description

Gene and Molecular Mechanisms

The NPPC gene spans 2 exons and 1 intron and is highly conserved across species, with >90% homology in mammals . Its precursor protein undergoes proteolytic cleavage by furin to yield CNP-53 (53 amino acids) and CNP-22 (22 amino acids), which bind to NPR-B receptors to stimulate cGMP production . This signaling pathway regulates chondrocyte proliferation and differentiation, critical for skeletal growth .

Physiological Roles

CNP, derived from NPPC, exerts paracrine effects in:

  • Skeletal Development: Inhibits FGFR3 signaling, promoting growth plate chondrocyte proliferation .

  • Vascular Regulation: Induces vasodilation via cGMP-mediated smooth muscle relaxation .

  • Endocrine Functions: Modulates hormone secretion in adrenal glands and pituitary .

Preclinical and Clinical Studies

Study FocusKey FindingsSource
Zebrafish Growth RegulationExogenous CNP reduced body length, head width, and eye diameter in embryos .
Achondroplasia TreatmentVosoritide (CNP analog) increased annualized growth velocity by 1.57 cm/year .
CNP Deficiency RescueTransgenic CNP overexpression restored growth in Nppc−/− mice .

Clinical Trials and Drug Development

  • Vosoritide: A recombinant CNP analog (39 amino acids) approved for achondroplasia. Phase 3 trials showed sustained height gains and mild side effects (e.g., injection-site reactions) .

  • CNP Deficiency: Missense mutations in NPPC (e.g., p.Arg117Gly) cause autosomal dominant short stature. CNP replacement therapy is under investigation .

Tissue Expression and Pathological Relevance

NPPC is expressed in diverse tissues, including:

TissueExpression LevelFunctional RoleSource
ChondrocytesHighGrowth plate regulation
Endothelial CellsModerateVascular tone modulation
Brain (Hippocampus, Amygdala)LowNeuroendocrine signaling

Stability and Handling

ParameterRecommendation
Storage-20°C for long-term; 4°C for short-term
Freeze-Thaw CyclesAvoid; add 0.1% HSA or BSA for stability
Purity>85% by SDS-PAGE

Product Specs

Introduction
Natriuretic peptide precursor C (NPPC) undergoes proteolytic processing to yield a secreted hormone belonging to the natriuretic peptide family. NPPC exhibits vasoactive and natriuretic properties, playing a role in regulating blood pressure and fluid balance. Moreover, it influences the growth and differentiation of chondrocytes within the cartilaginous growth plate, contributing to skeletal development.
Description
Recombinant human NPPC, expressed in E. coli, is a single, non-glycosylated polypeptide chain comprising 126 amino acids (residues 24-126) with a molecular weight of 13.2 kDa. This protein encompasses amino acids 24 to 126 of the NPPC sequence and incorporates a 23-amino acid His-tag at the N-terminus to facilitate purification using proprietary chromatographic techniques.
Physical Appearance
Clear solution subjected to sterile filtration.
Formulation
The NPPC solution is provided at a concentration of 0.25 mg/ml in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 0.15 M NaCl, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the NPPC solution should be stored at 4°C. For extended storage, it is recommended to freeze the solution at -20°C. To enhance stability during long-term storage, the addition of a carrier protein such as 0.1% HSA or BSA is advised. It is important to minimize repeated freeze-thaw cycles to maintain protein integrity.
Purity
The purity of the NPPC protein is determined to be greater than 85% as assessed by SDS-PAGE analysis.
Synonyms
Natriuretic Peptide Precursor C, C-Type Natriuretic Peptide, CNP2, CNP.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSKPGAPPK VPRTPPAEEL AEPQAAGGGQ KKGDKAPGGG GANLKGDRSR LLRDLRVDTK SRAAWARLLQ EHPNARKYKG ANKKGLSKGC FGLKLDRIGS MSGLGC

Q&A

What is NPPC and how does it function in human physiology?

NPPC (Natriuretic peptide precursor C) is a protein encoded by the NPPC gene in humans that serves as the precursor to C-type natriuretic peptide (CNP). Unlike other natriuretic peptides, CNP doesn't have direct natriuretic activity but functions through selective binding to the B-type natriuretic receptor (NPRB). NPPC belongs to a family of three structurally related molecules including atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), all implicated in body fluid homeostasis and blood pressure regulation. The primary distinction is that while ANP and BNP act through the A-type natriuretic receptor (NPRA), CNP derived from NPPC acts through NPRB, creating different downstream signaling pathways .

Where is NPPC primarily expressed and how is it regulated?

NPPC is synthesized and secreted primarily from vascular endothelium in response to various stimuli, particularly shear stress (similar to nitric oxide) and proinflammatory cytokines. Its expression pattern differs from other natriuretic peptides, with specific tissue distribution patterns that correlate with its physiological functions. The regulation occurs at both transcriptional and post-translational levels, with multiple factors influencing its secretion and processing from precursor to active peptide .

What are the structural characteristics of NPPC?

The NPPC gene encodes a precursor protein that undergoes proteolytic processing to form the 22-amino acid bioactive C-type natriuretic peptide (CNP). This structure is critical for its receptor binding specificity and subsequent biological activities. The mature CNP peptide contains a characteristic ring structure formed by disulfide bonding that is essential for its biological activity and receptor selectivity .

What approaches are most effective for measuring NPPC/CNP in human samples?

Quantitative analysis of NPPC/CNP requires sensitive detection methods due to potentially low circulating levels. Enzyme-linked immunosorbent assays (ELISAs) are commonly employed for plasma or serum protein concentration determinations. For researchers designing studies involving NPPC measurement, it's important to determine whether detecting the precursor NPPC or the cleaved CNP peptide is more relevant to your research question. Mass spectrometry-based approaches provide higher specificity when discriminating between different natriuretic peptides and their metabolites .

How should researchers approach NPPC gene expression analysis?

For gene expression studies, quantitative PCR remains the gold standard, though RNA sequencing provides broader context of expression patterns. When designing primers, researchers should account for potential splice variants and ensure specificity against other natriuretic peptide genes. Expression analysis should ideally be coupled with protein-level measurements to account for post-transcriptional regulation mechanisms .

What controls should be included in NPPC functional studies?

When conducting functional studies of NPPC/CNP, appropriate controls should include:

  • Comparison with other natriuretic peptides (ANP, BNP) to distinguish receptor-specific effects

  • Receptor antagonists to confirm pathway specificity

  • Dose-response relationships to establish physiological relevance

  • Consideration of tissue-specific effects when interpreting results

This multi-parameter approach helps distinguish NPPC-specific effects from general natriuretic peptide functions .

How can contradictory findings in NPPC research be reconciled?

Contradictory findings in NPPC research often stem from methodological differences, particularly in:

  • Sample processing techniques that may affect peptide stability

  • Assay specificity for precursor versus cleaved forms

  • Cross-reactivity with other natriuretic peptides

  • Population heterogeneity in study cohorts

Researchers should carefully evaluate methodological details when comparing studies with conflicting results. Statistical approaches like principal component analysis (PCA) may help identify patterns in data but should be used cautiously as PCA results can be artifacts of the data and easily manipulated to generate desired outcomes . When contradictions arise, meta-analyses or systematic reviews with clearly defined inclusion criteria are recommended to reconcile disparate findings.

What experimental designs best capture NPPC's physiological significance?

Optimal experimental designs for studying NPPC's physiological significance include:

Experimental ApproachAdvantagesLimitationsBest Applications
Transgenic modelsDirect manipulation of expression levelsCompensatory mechanisms may developMechanistic studies
Receptor knockout studiesPathway specificityMay affect multiple ligandsSignaling pathway analysis
Ex vivo tissue preparationsPreserved tissue architectureShort viability periodAcute response studies
In vivo physiological measurementsIntegrated systemic responsesComplex interpretationWhole-body homeostasis studies

Researchers should select experimental approaches based on their specific research question, recognizing that multi-modal approaches often provide the most comprehensive understanding .

How should researchers approach the analysis of NPPC genetic variations?

When studying genetic variations in NPPC, researchers should:

  • Distinguish between coding and regulatory variants

  • Assess evolutionary conservation to prioritize potentially functional variants

  • Consider population-specific frequencies in study design

  • Validate computational predictions with functional assays

Be cautious when interpreting population genetics studies using PCA, as this methodology has limitations in reliability and reproducibility. Research suggests that PCA results in genetic studies may not always be robust, with an estimated 32,000-216,000 genetic studies potentially requiring reevaluation due to over-reliance on PCA outcomes .

What methodological approaches are recommended for studying NPPC in cardiovascular disorders?

For cardiovascular research involving NPPC:

  • Measure both circulating levels and tissue expression

  • Consider temporal dynamics during disease progression

  • Integrate with hemodynamic measurements

  • Account for medication effects (especially those affecting the renin-angiotensin-aldosterone system)

  • Include appropriate control groups matched for comorbidities

This comprehensive approach provides context for interpreting NPPC alterations in disease states versus compensatory responses .

How can researchers differentiate pathological from compensatory changes in NPPC?

Distinguishing pathological from compensatory changes requires:

  • Longitudinal study designs capturing disease progression

  • Correlation with disease severity metrics

  • Mechanistic studies determining whether changes promote or inhibit pathological processes

  • Intervention studies that modulate NPPC/CNP levels or activity

The interpretation should consider NPPC's vasodilatory properties and its interactions with other regulatory systems in maintaining cardiovascular homeostasis .

What are the emerging techniques for NPPC-targeted therapeutic development?

Research approaches for NPPC-targeted therapies include:

  • Structure-based drug design targeting receptor specificity

  • Modified peptides with enhanced stability and bioavailability

  • Gene therapy approaches to modulate expression

  • Pathway-specific approaches that enhance beneficial effects while minimizing side effects

Robust preclinical validation should establish efficacy, specificity, and safety profiles before clinical translation .

How should NPPC research protocols be modified for pediatric applications?

Pediatric NPPC research requires:

  • Age-specific reference ranges

  • Consideration of developmental changes in expression and function

  • Scaled sampling volumes appropriate for pediatric subjects

  • Correlation with growth parameters, particularly for NPPC's potential role in bone growth

These adaptations account for developmental differences in NPPC physiology while maintaining ethical research standards for vulnerable populations .

What are the methodological challenges in studying NPPC in the context of blood proteomics?

Blood proteomics studies of NPPC face several challenges:

  • Low abundance relative to major plasma proteins

  • Short half-life of active peptides

  • Sample collection and processing affecting stability

  • Need for targeted enrichment strategies

  • Distinguishing between different processing forms

Researchers can address these challenges through optimized sample collection protocols, targeted enrichment approaches, and high-sensitivity mass spectrometry methods .

How can research bias be minimized when studying NPPC function?

To minimize bias in NPPC research:

  • Use blinded assessment for subjective outcomes

  • Pre-register study protocols and analysis plans

  • Include comprehensive controls for confounding variables

  • Report all tested outcomes, not just significant findings

  • Employ multiple methodological approaches to confirm findings

  • Be cautious with analytical methods like PCA that may introduce artifacts or be susceptible to manipulation

This approach aligns with broader efforts to address reproducibility challenges in scientific research.

Product Science Overview

Introduction

Natriuretic Peptide C (CNP) is a member of the natriuretic peptide family, which also includes Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP). These peptides play crucial roles in cardiovascular homeostasis by regulating blood pressure, blood volume, and sodium balance. CNP is encoded by the NPPC gene in humans .

Structure and Function

CNP is synthesized as a precursor protein, natriuretic peptide precursor C (NPPC), which is then cleaved to produce the active 22-amino acid peptide . Unlike ANP and BNP, which are primarily involved in cardiovascular regulation, CNP has a broader range of functions, including roles in bone growth, cartilage development, and reproductive processes .

Mechanism of Action

CNP exerts its effects by binding to natriuretic peptide receptors, specifically NPR-B, which is a receptor guanylyl cyclase. This binding leads to the production of cyclic guanosine monophosphate (cGMP), a secondary messenger that mediates various physiological effects . CNP is known for its vasodilatory, anti-proliferative, and anti-fibrotic properties, making it a potential therapeutic target for various cardiovascular and fibrotic diseases .

Clinical Applications

Recombinant human CNP has been explored for its therapeutic potential in treating conditions such as achondroplasia, a form of dwarfism caused by mutations in the FGFR3 gene. Clinical trials have shown that CNP can promote bone growth and improve skeletal abnormalities in affected individuals . Additionally, CNP’s cardiovascular benefits are being investigated for potential use in treating hypertension and heart failure .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.